America marches blindly toward single-payer, says PRI

17 May 2016
pacific-research-institute-logo-big

US Democrat presidential front runner Hillary Clinton just dipped her toe a little bit further into the waters of single-payer health care, prodded by her competitor for the Democratic presidential nomination, Senator Bernie Sanders, according to a posting on the website of the Pacific Research Institute think-tank.

Last week, she called for allowing more people to join Medicare - the government-run healthcare program for seniors - by allowing those “55 or 50 and up” to buy into it. Mr Sanders can no doubt take credit for pulling her further left - his proposal to expand Medicare to cover all Americans has evinced widespread cheers from his partisans, the PRI noted.

But the record of other single-payer systems at home and abroad should silence those cheers. Single-payer would devastate the quality of health care that patients receive in this country - and would rob them blind in the process.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical